HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $493,926 | +1.4% | 12,930 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $487,125 | +20.0% | 13,505 | +26.9% | 0.00% | 0.0% |
| Q1 2023 | $406,000 | -20.9% | 10,642 | +17.9% | 0.00% | -33.3% |
| Q4 2022 | $513,579 | +2.3% | 9,026 | -28.9% | 0.00% | 0.0% |
| Q3 2022 | $502,000 | +17.8% | 12,689 | +31.2% | 0.00% | +50.0% |
| Q2 2022 | $426,000 | -78.9% | 9,673 | -79.6% | 0.00% | -81.8% |
| Q4 2020 | $2,022,000 | -10.2% | 47,332 | -44.8% | 0.01% | -15.4% |
| Q3 2020 | $2,252,000 | -5.0% | 85,700 | -3.1% | 0.01% | -13.3% |
| Q2 2020 | $2,371,000 | -34.9% | 88,453 | -56.3% | 0.02% | -44.4% |
| Q1 2020 | $3,642,000 | – | 202,457 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |